Meeting
2018 Genitourinary Cancers Symposium
The prospective assessment of the prostatic cancer mortality with PSA progression in the groups treated or not treated by salvage local brachytherapy.
Authors
Karol Edward Nietupski
Centru Onkologii - Instytut, Otwock, Poland
Karol Edward Nietupski , Anna Kulik , Pawel Wiechno , Tomasz Demkow , Piotr Peczkowski , Małgorzata Pilichowska , Grazyna Maria Poniatowska , Wojciech Michalski , Joanna Rzymkowska , Malgorzata Sadowska , Marcin Ligaj , Jakub Kucharz , Joanna Jonska-Gmyrek , Ewa Wieczorek , Katarzyna Stencel
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 85)
DOI
10.1200/JCO.2018.36.6_suppl.85
Abstract #
85
Poster Bd #
E5
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Effect of prostate brachytherapy case volume in the community setting on oncologic outcomes.
First Author: Kevin Chang
Poster
2018 Genitourinary Cancers Symposium
Long-term outcomes of magnetic resonance image-guided partial prostate brachytherapy for favorable-risk prostate cancer.
First Author: Martin T. King
Poster
2024 ASCO Genitourinary Cancers Symposium
Real-world analyses of mortality risk after androgen deprivation therapy initiation in Black vs. White patients with prostate cancer.
First Author: Judd W. Moul
Poster
2024 ASCO Genitourinary Cancers Symposium
Phase II trial of ArtemiCoffee for men with biochemical recurrence of prostate cancer after local therapy.
First Author: Zin Myint